192 filings
Page 5 of 10
6-K
5jquf4v8 lg
4 Jun 19
Affimed Announces Annual General Meeting of Shareholders
4:16pm
6-K
mec5txd9q467wqqwkhk
22 May 19
Current report (foreign)
7:37am
6-K
sdmh8cu33 vg4wee
17 Apr 19
Affimed Provides Regulatory Update on AFM11 Clinical Program
4:10pm
6-K
fix78wi
7 Jan 19
Actualizing the Untapped Potential of the Innate Immune System Affimed’s Approach to Advancing Immuno - oncology January 2019
7:01am
424B5
50a e95cy3m2
8 Nov 18
Prospectus supplement for primary offering
4:31pm
EFFECT
lopvphh
8 Nov 18
Notice of effectiveness
12:15am
6-K
q007fc t6
7 Nov 18
Condensed Consolidated Financial Statements
7:31am
UPLOAD
ate m0olszezghhdwjv
6 Nov 18
Letter from SEC
12:00am
CORRESP
pevae4
5 Nov 18
Correspondence with SEC
12:00am
6-K
308i0 wce
1 Nov 18
Affimed Announces Oral Presentation and Five Poster Presentations at the 2018 American Society of Hematology Annual Meeting
9:20am
F-3
q48ibk6kzeeu6v7je
22 Oct 18
Shelf registration (foreign)
4:32pm
6-K/A
gkso9qkc9pkiycntn
16 Oct 18
Current report (foreign) (amended)
4:30pm
6-K
spwlay3
9 Oct 18
Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold
6:05am
CT ORDER
chnbl8eq
17 Sep 18
Confidential treatment order
12:00am
6-K
2nbmo34oklg8bnwphfu4
27 Aug 18
Current report (foreign)
12:00am
6-K
eoqvcb0b 5a
8 Aug 18
Index to Condensed Consolidated Financial Statements
7:30am
6-K
9wmnlsio fy
20 Jun 18
Current report (foreign)
4:15pm
6-K
c68ztebv6tu 2p
15 Jun 18
Current report (foreign)
12:00am
6-K
qfbj1yemw 4iqgmhpctp
18 May 18
Affimed Announces Annual General Meeting of Shareholders
4:17pm